Application Notes & Case Studies

1. Fortrea Optimizes Site Matching On Retina Clinical Trials 6/27/2025

   Faced with challenges in engaging clinical trial sites within the retina research landscape, Fortrea sought a partnership that leverages RWD to streamline site feasibility assessments.

2. Pioneering Cancer Research Meets Unparalleled Veeva Vault Integration 6/26/2025

   A biotech company revolutionizing cancer treatment faced delays due to a complex, error-prone document review process. Discover how integrating an innovative strategy transformed their workflow.

3. Rapid Results In A High-Stakes Dry Eye Disease Trial 6/26/2025

   This time-sensitive Phase III trial in dry eye disease required precision project management leveraging strong site relationships, ophthalmology-specific expertise, and data-driven site selection.

4. Global Start-Up For Multinational Geographic Atrophy Trial 6/26/2025

   This partnership allowed a leading biopharmaceutical company to navigate the complexities of a Phase IIb study investigating a novel pegylated RNA adapter for geographic atrophy secondary to dry AMD.

5. Data Key In Addressing Patient Recruitment Challenges 6/19/2025

   Explore how a Phase II trial for extensive-stage and previously treated small cell lung cancer overcame recruitment challenges with a data-driven solution designed to surface protocol-matched patients.

6. Precision Project Management In Action 6/12/2025

   Discover how a tailored, risk-based project management approach was used to overcome the challenges of a complex Phase I/IIa FIH multi-country study of an advanced therapy medicinal product (ATMP).

7. Optimizing EDC Strategy And Data Collection for a Rare Disease Trial 6/11/2025

   Explore how Veristat created a forward-looking roadmap for EDC and CRFs integration for a small biotech sponsor, ensuring a future-ready data ecosystem without overcomplicating current operations.

8. When Science And Humanity Become Inseparable 6/11/2025

   Learn how kindness transformed the clinical trial experience for pediatric rare disease participants in a global study.

9. Running A 697-Patient MS Study Through Crisis And Complexity 6/10/2025

   Review an ongoing Phase III open-label extension study evaluating the long-term safety and efficacy of ublituximab in patients with relapsing multiple sclerosis.

10. Boosting Recruitment Strategy For Phase III Study In Ulcerative Colitis 6/10/2025

    Learn about the successful execution of a challenging three-arm, randomized, placebo-controlled Phase 3 study in Ulcerative Colitis despite strict inclusion criteria and a limited patient pool.